November 26, 2024
TOPLINE: The high incidence of acute hyponatremia after the administration of a single dose of 3,4-methylenedioxymethamphetamine (MDMA), also known as ecstasy, in healthy individuals may be […]
November 21, 2024
TOPLINE: Denosumab treatment for osteoporosis raises the risk for hypocalcemia, which worsens with advancing stages of chronic kidney disease (CKD), in those with CKD–Mineral and Bone […]
November 11, 2024
The search for a better biomarker than creatine for acute kidney injury (AKI) has been “long and elusive.” However, could researchers be on the right path […]
November 5, 2024
TOPLINE: Greater exposure to per- and polyfluoroalkyl substances (PFAS) is linked to reduced kidney function in young adults, mediated by changes in the gut microbiome and […]
November 4, 2024
TOPLINE: A fasting-mimicking diet (FMD) restored kidney function in a rodent model and promoted renoprotection in patients with chronic kidney disease (CKD) by reducing proteinuria and […]
November 1, 2024
SAN DIEGO – Patients receiving cancer treatment, while having an increased risk for acute kidney injury (AKI) linked to various cancer treatment regimens, show no higher […]
October 29, 2024
SAN DIEGO — The investigational drug pegcetacoplan, a C3/C3b inhibitor, showed significant benefits in the treatment of patients with C3 glomerulopathy or primary immune complex–mediated membranoproliferative […]
October 28, 2024
SAN DIEGO — The significant kidney and cardiovascular benefits people with chronic kidney disease (CKD) show over 2 years of treatment with empagliflozin begin to subside […]
October 27, 2024
SAN DIEGO — Dapagliflozin provides significant benefits in the treatment of chronic kidney disease (CKD) even when initiated in patients with the most severe stages of […]